F52.9 Unspecified sexual dysfunction not due to a substance or known physiological condition
F66 Other sexual disorders (e.g. increased libido)
See also Gender Identity Disorders and Paraphilias
References
[Davis2001]   Susan R Davis, Jane Tran.
Testosterone influences libido and well being in women.
Trends in Endocrinology & Metabolism 12(1):33-37 (January 2001).
PMID: 11137039 Full text:
https://www.cell.com/trends/endocrinology-metabolism/fulltext/S1043-2760(00)00333-7
Accessed: 11/1/2019.
[Davis2005]   Susan R Davis, Michele Moreau, Robin Kroll, Céline Bouchard, Nick Panay, Margery Gass, Glenn D Braunstein, Angelica Linden Hirschberg, Cynthia Rodenberg, Simon Pack, Helga Koch, Alain Moufarege, John Studd.
Testosterone for low libido in postmenopausal women not taking estrogen.
N Engl J Med. 2008 Nov 6;359(19):2005-17.
PMID: 18987368 Full text:
https://www.nejm.org/doi/full/10.1056/NEJMoa0707302
Accessed: 11/01/2019.
[Davis2009]   Susan R Davis.
Testosterone for low libido in postmenopausal women not using systemic oestrogen therapy.
Med J Aust. 2009 Aug 3;191(3):134-5.
PMID: 19645638
[Friedman2013]   Edward Friedman, William Cane.
The New Testosterone Treatment: How You and Your Doctor Can Fight Breast Cancer, Prostate Cancer,
and Alzheimer's.
Prometheus Books (2013).
Amazon
This is an excellent presentation of recent advances in the understanding
of hormone receptors and their relationship to prostate cancer, breast cancer,
and Alzheimer's disease.
However, the author does not consider the possibility
of epigenetic changes due to long-term exposure to hormones that may span
multiple generations of cells, resulting in cumulative changes in gene expression.
In addition, the author proposes that the lengthening of telomeres is a necessary
step in cell immortalization in cancer. Dr. Weyrich notes that other researchers
have proposed lengthening of telomeres to be a positive outcome that should be
promoted by various interventions.
[Hinz2015]   Martin C Hinz.
Managing Relative Nutritional Deficiencies associated with the centrally
acting monoamines (Serotonin, Dopamine, Norepinephrine and/or Epinephrine.
Neuro Research Clinics. AMA Category 1 Continuing Medical Education seminar.
September 26, 2015, Phoenix, AZ.
Note
Dr. Weyrich's Naturopathic Functional Medicine Notebook is a collection of information on
topics of interest to Dr. Weyrich that may be of interest to the world wide audience.
Due to limitations of time, not all information that Dr. Weyrich knows or would like to further
research is published here.
Dr. Weyrich welcomes financial contributions to support specific research topics, as well as
copies of non-free access journal articles for him to review on a topic.
Constructive criticism is also welcome.
Disclaimers
Copyright © 2007-2024 Dr. Weyrich.
FDA: The information on this site is for educational purposes only.
It is not intended to diagnose, treat or cure any disease or illness.
The statements on this website have not been evaluated by the Food and Drug
Administration.
If you have a health concern or medical condition, consult a licensed
healthcare provider.
Dr. Weyrich is a physician licensed to practice as a Naturopathic Medical Doctor
(NMD) in Arizona.
FTC: Links to external web sites that are not under the control of
Dr. Weyrich are flagged with a small image of the world.
Dr. Weyrich may earn a nominal sales commission from purchases
made on external web sites such as Amazon. Links to these sites are flagged by
a yellow dollar sign. Links to external sites are for informational purposes
and do not represent recommendations to purchase. When possible, buy local.
HIPAA: This web site does not collect personally identifiable information,
and does not use cookies. Dr. Weyrich has no control over external web sites.
Phone for Dr. Weyrich:
(888) 391-0414
This web page is https://drweyrich.com/disorders/sex.html